Results 21 to 30 of about 621 (85)

Malignant Rhabdoid Tumors of the Liver Are Associated With Inferior Outcomes Compared to Other Extracranial Rhabdoid Tumors

open access: yesPediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Extracranial malignant rhabdoid tumors (eMRT) are rare, highly aggressive pediatric neoplasms. While the liver is a relatively common anatomic site of presentation, the clinical course of patients with hepatic eMRT (eMRT‐L) is not well described.
Sebastian Bühner   +16 more
wiley   +1 more source

Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study

open access: yesMalignancy Spectrum, Volume 2, Issue 3, Page 128-139, September 2025.
Abstract Objective There is a paucity of real‐world evidence in the Indian context to address the outcome of primary brain tumors (PBTs) in children. This study aimed to describe the demographic profile, clinical characteristics, and histological features of PBTs based on the 2016 World Health Organization classification, assess the efficacy of ...
Priyadharshini Veeralakshmanan   +10 more
wiley   +1 more source

Congenital Intracranial Tumors: Prenatal Diagnosis by Fetal Magnetic Resonance Imaging

open access: yesiRADIOLOGY, Volume 3, Issue 3, Page 203-208, June 2025.
Fetal intracranial tumors are rare, comprising 0.5%–1.9% of all childhood tumors, with their true incidence potentially underestimated. This review highlights the role of fetal MRI, particularly with advanced sequences, in diagnosing common fetal brain tumors such as teratomas, astrocytomas, and choroid plexus papillomas, often presenting unique ...
Jing‐Ya Ren   +3 more
wiley   +1 more source

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft model

open access: yesHemaSphere, Volume 9, Issue 3, March 2025.
Abstract Vincristine is one of the most important chemotherapeutic drugs used to treat acute lymphoblastic leukemia (ALL). Unfortunately, vincristine often causes severe adverse effects, including sensory–motor neuropathies, weight loss, and overall decreased well‐being, that are difficult to control and that decrease the quality of life and survival ...
Hana Starobova   +8 more
wiley   +1 more source

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, Volume 196, Issue 4, December 2024.
Abstract Neurofibromatosis type 1 (NF‐1) microdeletion syndrome accounts for 5 to 11% of individuals with NF‐1. The aim of our study was to characterize a large cohort of individuals with NF‐1 microdeletion syndrome and expand its natural history.
Jenny P. Garzon   +19 more
wiley   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +2 more sources

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ISEV2025 Abstract Book

open access: yes
Journal of Extracellular Vesicles, Volume 14, Issue S1, October 2025.
wiley   +1 more source

Stroke-like migraine attack after radiation therapy (SMART) syndrome in a pediatric patient with a ventriculoperitoneal shunt: illustrative case. [PDF]

open access: yesJ Neurosurg Case Lessons
Lozano CS   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy